In breast cancer cells, the overexpression of miR-191-5p resulted in a lower number of apoptotic bodies and a decrease in caspase-3/-7 activity, whereas anti-miR-191-5p reverted this effect. This evidence concerns the gene CASP3 and breast carcinoma.